SPX4,149.99+92.15 2.27%
DIA331.50+5.05 1.55%
IXIC12,103.45+362.80 3.09%

--JPMorgan Adjusts Price Target for Merck & Company to $100 From $95, Maintains Overweight Rating

MT Newswires · 04/29/2022 07:30

Please log in to view news